- Home
- BCG vs BEAT Comparison
BCG vs BEAT Comparison
Compare BCG & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BCG | BEAT |
|---|---|---|
| Founded | 2016 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Retail: Computer Software & Peripheral Equipment |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.7M | 27.7M |
| IPO Year | 2025 | 2021 |
Fundamental Metrics
Financial Performance| Metric | BCG | BEAT |
|---|---|---|
| Price | $1.30 | $0.43 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $5.63 |
| AVG Volume (30 Days) | 54.8K | ★ 399.6K |
| Earning Date | 05-14-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 112.50 | 15.07 |
| EPS | ★ 0.08 | N/A |
| Revenue | ★ $187,144,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $315.97 |
| P/E Ratio | $16.50 | ★ N/A |
| Revenue Growth | ★ 10.80 | N/A |
| 52 Week Low | $1.26 | $0.42 |
| 52 Week High | $3.44 | $4.00 |
Technical Indicators
Market Signals| Indicator | BCG | BEAT |
|---|---|---|
| Relative Strength Index (RSI) | 37.97 | 32.47 |
| Support Level | $1.26 | N/A |
| Resistance Level | $1.58 | $0.52 |
| Average True Range (ATR) | 0.07 | 0.02 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 3.64 | 1.31 |
Price Performance
Historical ComparisonAbout BCG Binah Capital Group Inc.
Binah Capital Group Inc formerly Wentworth Management Services LLC is a holding company that acquires and manages businesses in the wealth management industry. The company specializes in consolidating independent broker-dealers to capture economies of scale needed to service financial advisors in today's technology-enabled regulatory environment. Wentworth's core philosophy focuses on building long-term, productive relationships with its advisor base.
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.